SCIENTURE HOLDINGS, INC. Shareholders' Equity
SCIENTURE HOLDINGS, INC. (SCNX) had Shareholders' Equity of $64.10 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $64.10M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $66.82M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $70.12M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $82.67M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $64.10M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $66.82M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $70.12M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $82.67M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $77.86M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $81.16M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $79.07M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $85.13M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $11.79M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $13.62M 10-Q · filed 2025-11-12 |
| 2023-12-31 | $542.35K 10-K · filed 2026-03-30 |
| 2023-09-30 | $11.56M 10-Q · filed 2024-01-16 |
| 2023-06-30 | -$1.29M 10-Q · filed 2023-08-18 |
| 2023-03-31 | $655.14K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $763.14K 10-K · filed 2024-04-22 |
| 2022-09-30 | $1.40M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $1.82M 10-Q · filed 2022-07-25 |
| 2022-03-31 | $2.87M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $3.77M 10-K · filed 2023-03-27 |
| 2021-09-30 | $4.62M 10-Q · filed 2021-10-25 |
| 2021-06-30 | $5.79M 10-Q · filed 2021-10-25 |
| 2021-03-31 | $8.20M 10-Q · filed 2021-10-25 |
| 2020-12-31 | $8.68M 10-K · filed 2022-03-28 |
| 2020-09-30 | $10.83M 10-Q · filed 2021-10-25 |
| 2020-06-30 | $10.15M 10-Q · filed 2021-10-25 |
| 2020-03-31 | $9.64M 10-Q · filed 2021-10-25 |
| 2019-12-31 | $4.14M 10-K · filed 2022-03-28 |
| 2019-09-30 | $3.89M 10-Q · filed 2020-10-26 |
| 2019-06-30 | $1.34M 10-Q · filed 2020-10-26 |
| 2019-03-31 | $1.22M 10-Q · filed 2020-10-26 |
| 2018-12-31 | $844.67K 10-K · filed 2021-03-29 |
| 2018-09-30 | $325.59K 10-Q · filed 2019-10-28 |
| 2018-06-30 | -$121.08K 10-Q · filed 2019-10-28 |
| 2018-03-31 | -$192.21K 10-Q · filed 2019-10-28 |
| 2017-12-31 | -$311.93K 10-K · filed 2020-03-30 |
| 2017-09-30 | -$497.62K 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$636.13K 10-Q · filed 2017-08-04 |
| 2016-12-31 | -$1.15M 10-K · filed 2019-03-22 |
| 2015-12-31 | $267.02K 10-K · filed 2016-03-28 |
| 2015-09-30 | $380.23K 10-Q · filed 2015-11-02 |
| 2015-06-30 | $447.33K 10-Q · filed 2015-07-30 |
| 2015-03-31 | $340.86K 10-Q · filed 2015-05-04 |
| 2014-12-31 | $668.44K 10-K · filed 2016-03-28 |
| 2014-09-30 | $213.80K 10-Q · filed 2014-10-30 |
| 2014-06-30 | -$76.11K 10-Q · filed 2014-08-21 |
| 2013-12-31 | $130.87K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |